Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

PIK3CA mutations in oligodendroglial tumours.

Hartmann C, Devermann L, Gehlhaar C, Holtkamp N, von Deimling A.

Neuropathol Appl Neurobiol. 2006 Apr;32(2):209-12. No abstract available.

PMID:
16599949
2.

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.

Sonoda Y, Kumabe T, Nakamura T, Saito R, Kanamori M, Yamashita Y, Suzuki H, Tominaga T.

Cancer Sci. 2009 Oct;100(10):1996-8. doi: 10.1111/j.1349-7006.2009.01270.x.

3.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.

Acta Neuropathol. 2009 Oct;118(4):469-74. doi: 10.1007/s00401-009-0561-9. Epub 2009 Jun 25.

PMID:
19554337
4.

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

Catasus L, Gallardo A, Cuatrecasas M, Prat J.

Mod Pathol. 2009 Apr;22(4):522-9. doi: 10.1038/modpathol.2009.5. Epub 2009 Feb 20.

5.

Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II.

Stockhammer F, von Deimling A, van Landeghem FK.

Histopathology. 2009 Jan;54(2):241-7. doi: 10.1111/j.1365-2559.2008.03153.x.

PMID:
19207949
6.

Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.

Riener MO, Bawohl M, Clavien PA, Jochum W.

Genes Chromosomes Cancer. 2008 May;47(5):363-7. doi: 10.1002/gcc.20540.

PMID:
18181165
7.

PIK3CA mutation associates with improved outcome in breast cancer.

Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, Hedvat CV, Traina TA, Solit D, Gerald W, Moynahan ME.

Clin Cancer Res. 2009 Aug 15;15(16):5049-59. doi: 10.1158/1078-0432.CCR-09-0632. Epub 2009 Aug 11.

8.

PIK3CA, HRAS and KRAS gene mutations in human penile cancer.

Andersson P, Kolaric A, Windahl T, Kirrander P, Söderkvist P, Karlsson MG.

J Urol. 2008 May;179(5):2030-4. doi: 10.1016/j.juro.2007.12.040. Epub 2008 Mar 19.

PMID:
18355852
9.

PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.

Liedtke C, Cardone L, Tordai A, Yan K, Gomez HL, Figureoa LJ, Hubbard RE, Valero V, Souchon EA, Symmans WF, Hortobagyi GN, Bardelli A, Pusztai L.

Breast Cancer Res. 2008;10(2):R27. doi: 10.1186/bcr1984. Epub 2008 Mar 27.

10.

Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.

Hafner C, Vogt T, Landthaler M, Müsebeck J.

Br J Dermatol. 2008 Jul;159(1):214-7. doi: 10.1111/j.1365-2133.2008.08626.x. Epub 2008 Jul 1.

PMID:
18503601
11.

PIK3CA gene mutations in breast carcinoma in Malaysian patients.

Ching-Shian Leong V, Jabal MF, Leong PP, Abdullah MA, Gul YA, Seow HF.

Cancer Genet Cytogenet. 2008 Dec;187(2):74-9. doi: 10.1016/j.cancergencyto.2008.07.005.

PMID:
19027487
12.

Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.

Maruyama N, Miyoshi Y, Taguchi T, Tamaki Y, Monden M, Noguchi S.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):408-14. Epub 2007 Jan 3.

13.

DNA release by line-1 (L1) retrotransposon. Could it be possible?

Alves G, Kawamura MT, Nascimento P, Maciel C, Oliveira JA, Teixeira A, Carvalho Mda G.

Ann N Y Acad Sci. 2000 Apr;906:129-33.

PMID:
10818608
14.

Analysis of the IDH1 codon 132 mutation in brain tumors.

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A.

Acta Neuropathol. 2008 Dec;116(6):597-602. doi: 10.1007/s00401-008-0455-2. Epub 2008 Nov 5.

PMID:
18985363
15.

PIK3CA mutation status in Japanese lung cancer patients.

Kawano O, Sasaki H, Endo K, Suzuki E, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Nov;54(2):209-15. Epub 2006 Aug 22.

PMID:
16930767
16.

Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.

Emblem KE, Scheie D, Due-Tonnessen P, Nedregaard B, Nome T, Hald JK, Beiske K, Meling TR, Bjornerud A.

AJNR Am J Neuroradiol. 2008 Oct;29(9):1664-70. doi: 10.3174/ajnr.A1182. Epub 2008 Jun 26.

17.

PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.

Catasus L, Gallardo A, Cuatrecasas M, Prat J.

Mod Pathol. 2008 Feb;21(2):131-9. Epub 2007 Dec 14.

18.

EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors.

Franco-Hernandez C, Martinez-Glez V, Arjona D, de Campos JM, Isla A, Gutierrez M, Vaquero J, Rey JA.

Cancer Genet Cytogenet. 2007 Feb;173(1):63-7.

PMID:
17284372
19.

Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.

Fenic I, Steger K, Gruber C, Arens C, Woenckhaus J.

Oncol Rep. 2007 Jul;18(1):253-9.

PMID:
17549376
20.

Mutations in PIK3CA are infrequent in neuroblastoma.

Dam V, Morgan BT, Mazanek P, Hogarty MD.

BMC Cancer. 2006 Jul 5;6:177.

Supplemental Content

Support Center